[HTML][HTML] The case for early use of glucagon-like peptide-1 receptor agonists in obstructive sleep apnea patients with comorbid diabetes and metabolic syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - mdpi.com
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - ui.adsabs.harvard.edu
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome.
R Sultana, F Sissoho, VP Kaushik… - Life (Basel, Switzerland …, 2022 - europepmc.org
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - search.proquest.com
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - researchexperts.utmb.edu
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik… - Life (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
[HTML][HTML] The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - ncbi.nlm.nih.gov
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
[PDF][PDF] The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome
R Sultana, F Sissoho, VP Kaushik, MA Raji - Life, 2022 - pdfs.semanticscholar.org
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
The Case for Early Use of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Patients with Comorbid Diabetes and Metabolic Syndrome.
R Sultana, F Sissoho, VP Kaushik… - Life (2075-1729 …, 2022 - search.ebscohost.com
Patients with obstructive sleep apnea (OSA) have high rates of co-occurring type 2 diabetes,
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …
hypertension, obesity, stroke, congestive heart failure, and accelerated atherosclerotic …